SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $608,251 | +355.6% | 12,936 | +306.5% | 0.06% | +75.0% |
| Q1 2023 | $133,517 | +13251.7% | 3,182 | +15052.4% | 0.03% | – |
| Q3 2022 | $1,000 | – | 21 | +600.0% | 0.00% | – |
| Q2 2022 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -98.6% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | -80.0% | 74 | -71.3% | 0.00% | -83.3% |
| Q2 2021 | $15,000 | – | 258 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |